Blood culture and susceptibility results and allergy history do not influence fluoroquinolone use in the treatment of community-acquired pneumonia.

about

An antimicrobial stewardship program with a focus on reducing fluoroquinolone overuse.

P2860

Q37498877-B4F122B4-629E-4840-AA29-5B503D3368A1

P2860

Blood culture and susceptibility results and allergy history do not influence fluoroquinolone use in the treatment of community-acquired pneumonia.

Item

http://www.wikidata.org/entity/Q45936465

description

2005 nî lūn-bûn

@nan

2005年の論文

@ja

2005年学术文章

@wuu

2005年学术文章

@zh

2005年学术文章

@zh-cn

2005年学术文章

@zh-hans

2005年学术文章

@zh-my

2005年学术文章

@zh-sg

2005年學術文章

@yue

2005年學術文章

@zh-hant

name

Blood culture and susceptibili ...... community-acquired pneumonia.

@en

Blood culture and susceptibili ...... community-acquired pneumonia.

@nl

type

Item

label

Blood culture and susceptibili ...... community-acquired pneumonia.

@en

Blood culture and susceptibili ...... community-acquired pneumonia.

@nl

prefLabel

Blood culture and susceptibili ...... community-acquired pneumonia.

@en

Blood culture and susceptibili ...... community-acquired pneumonia.

@nl

P1476

Blood culture and susceptibili ...... community-acquired pneumonia.

@en

P2093

B Joseph Guglielmo

http://www.w3.org/2001/XMLSchema#string

Claudette Greenway

http://www.w3.org/2001/XMLSchema#string

Cynthia K Murray

http://www.w3.org/2001/XMLSchema#string

Dale W Bratzler

http://www.w3.org/2001/XMLSchema#string

Nancy N Chang

http://www.w3.org/2001/XMLSchema#string

Peter M Houck

http://www.w3.org/2001/XMLSchema#string

P2860

The impact of blood cultures on antibiotic therapy in pneumococcal pneumonia.

Management of community-acquired pneumonia in the era of pneumococcal resistance: a report from the Drug-Resistant Streptococcus pneumoniae Therapeutic Working Group.

Increasing prevalence of multidrug-resistant Streptococcus pneumoniae in the United States.

Antibiotic resistance among gram-negative bacilli in US intensive care units: implications for fluoroquinolone use.

Surveillance for antimicrobial susceptibility among clinical isolates of Pseudomonas aeruginosa and Acinetobacter baumannii from hospitalized patients in the United States, 1998 to 2001

Update of practice guidelines for the management of community-acquired pneumonia in immunocompetent adults.

Clinical utility of blood cultures in adult patients with community-acquired pneumonia without defined underlying risks.

Antibiotic selective pressure and development of bacterial resistance.

A nosocomial outbreak of fluoroquinolone-resistant Streptococcus pneumoniae.

Epidemiology and frequency of resistance among pathogens causing urinary tract infections in 1,510 hospitalized patients: a report from the SENTRY Antimicrobial Surveillance Program (North America).

P304

59-66

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1592/PHCO.25.1.59.55627

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2005-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

15767221

http://www.w3.org/2001/XMLSchema#string

Blood culture and susceptibility results and allergy history do not influence fluoroquinolone use in the treatment of community-acquired pneumonia.

about

P2860

P2860

Blood culture and susceptibility results and allergy history do not influence fluoroquinolone use in the treatment of community-acquired pneumonia.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P577

P698

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P577

P698